The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.
Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding .
Request for Proposals (Contracts)
Notice of Funding Opportunities
Title
Announcement Number
Activity Code
Clinical Trials Status
Expiration Date
Sort descending
Program Official
HEAL Initiative Partnerships to Advance INterdisciplinary (PAIN) Training in Clinical Pain Research: The HEAL PAIN Cohort Program
RFA-NS-24-015 (T90/R90 Independent Clinical Trial Not Allowed)
R90, T90
Clinical Trial Not Allowed
09/27/2023
Rachel Altshuler, Ph.D.
Assay Validation of High Quality Markers for Clinical Studies in Cancer
PAR-20-313 (UH2/UH3 Clinical Trial Not Allowed)
UH2, UH3
Clinical Trial Not Allowed
10/11/2023
Lynn Sorbara, Ph.D.
Assay Validation of High Quality Markers for Clinical Studies in Cancer
PAR-20-314 (UH3 Clinical Trials Not Allowed)
UH3
10/11/2023
Lynn Sorbara, Ph.D.
HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics]
RFA-NS-22-052 (U19 Clinical Trial Not Allowed)
U19
Clinical Trial Not Allowed
10/11/2023
Rachel Altshuler, Ph.D.
Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health
RFA-CA-24-005 (U01 Clinical Trial Optional)
U01
Clinical Trial Optional
10/14/2023
Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
HEAL Initiative: Toward Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required)
RFA-AT-24-003
Clinical Trial Required
10/19/2023
HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics
RFA-NS-24-018 (UG3/UH3 Clinical Trial Optional)
UH3, UG3
Clinical Trial Optional
10/24/2023
HEAL Initiative: HEAL KIDS (Knowledge, Innovation and Discovery Studies) Pain: Acute Pain Clinical Trials Program
RFA-HD-24-011 (U01 Clinical Trial Required)
U01
Clinical Trial Required
11/21/2023
Brennan Streck, Ph.D., R.N., M.P.H.
Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries
RFA-CA-23-033 (U01 Clinical Trial Optional)
U01
Clinical Trial Optional
12/16/2023
Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Stephen I. Katz Early Stage Investigator Research Project Grant
PAR-21-039 (R01 Basic Experimental Studies with Humans Required)
R01
12/29/2023